期刊文献+

药物流行病学研究中的一次数据源介绍 被引量:5

Primary Data Sources in Pharmacoepidemiology Studies
下载PDF
导出
摘要 健康医疗数据是开展药物流行病学研究的基石,为药物使用、疾病防控、健康管理规划提供支撑。本研究以《中国药物流行病学研究方法学指南》为基础,从数据源和数据收集方法概述、国内外数据源现状、存在的问题、相应解决方案、案例分析等方面进行系统综述,介绍药物流行病学研究中一次数据及数据收集方法的特点,为开展药物流行病学研究时恰当地选择数据源及研究方法提供参考依据。 Data is the cornerstone of scientific research. The data sources in pharmacoepidemiology research can provide rich resources and professional background. The analysis results can support drug use, disease control and prevention, and health management planning. Based on the Guide on Methodological Standards in Pharmacoepidemiology, this overview systematically summarized the data source and data collection method for pharmacoepidemiology researches. Aims to provide references for the proper selection of primary data sources and research methods for further investigation, we also exemplified the domestic and foreign data sources accessible for current studies and corresponding pros and cons of the data sources.
作者 卓琳 贾敏 沈智文 张灵健 王俊彦 孙凤 王巍巍 宫建 詹思延 Zhuo Lin;Jia Min;Shen Zhiwen;Zhang Lingjian;Wang Junyan;Sun Feng;Wang Weiwei;Gong Jian;Zhaii Siyan(Research Center of Clinical Epidemiology,Peking University Third Hospital,Beijing 100191,China;Research Group of Jian Gong on Pharmacoepidemiology and Clinical Drug Evaluation,Shenyang Pharmaceutical University;Department of Pharmacy,School of General Hospital of Northern Theater Command,China Medical University;Department of Epidemiology and Bio-statistics,School of Public Health,Peking University;National Clinical Research Center for Mental Disorders&Beijing Key Laboratory of Mental Disorders,Beijing Anding Hospital,Capital Medical University)
出处 《药物流行病学杂志》 CAS 2021年第3期151-154,共4页 Chinese Journal of Pharmacoepidemiology
基金 北京大学医学部教育教学研究课题项目(编号:2020YB03)。
关键词 药物流行病学 数据源 一次数据 数据采集 Pharmacoepidemiology Data source Primary data Data collection
  • 相关文献

参考文献8

二级参考文献63

  • 1陈锋,杨世民.我国药物不良反应监测体系建设现状与存在的问题[J].医药导报,2006,25(5):486-488. 被引量:58
  • 2Mcbride W G.Thalidomide and congenital abnormalities[J].Lancet,19611 Ⅰ,271. 被引量:1
  • 3Wiholm B-E,Olsson S,Moore N,et al.Spontaneous reporting systems outside the US[J].Pharmacoepidemiology(3rd ed):Strom B.John Wiley & Sons,Ltd,Chichester,2000,175-192. 被引量:1
  • 4Almenoff J,Tonning J M,Lawrence Gould A,et al.Perspectives on the use of data mining in Pharmacovigilance[J].Drug Safety,2005,28 (11):981-1007. 被引量:1
  • 5EMEA.Guideline on the use of statistical signal detection methods in the Eudravigilance DataAnalysisSystem[EB/OL].http://www.emea.europa.eu/pdfs/human/phvwp/10646406enfin.pdf,London,26June 2008.Doc.Ref.EMEA/106464/2006 rev. 被引量:1
  • 6药品不良反应报告和监测管理办法[s].卫生部令第81号,2011. 被引量:4
  • 7崔燕宁.药物安全与药物警戒[M].北京:人民卫生出版社,2014:122. 被引量:2
  • 8Xia YY, Hu DY, Liu FY, et al. Design of the anti-tubercu- losis drugs induced adverse reactions in China National Tu- berculosis Prevention and Control Scheme Study (ADACS) [J]. BMC Public Health, 2010, 10:267. 被引量:1
  • 9Shang P, Xia Y, Liu F, et al. Incidence, clinical features and impact on anti-tuberculosis treatment of anti-tuberculosis drug induced liver injury (ATLI) in China [ J ]. PloS One, 2011, 6(7): e21836. 被引量:1
  • 10Schneeweiss S, Avorn J. A review of uses of health care uti- lization databases for epidemiologic research on therapeutics [J]. J Clin Epidemiol, 2005, 58(4) : 323-337. 被引量:1

共引文献608

同被引文献40

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部